Skip to Main Content

Author Details

Curtis A Lachowiez
University of Texas MD Anderson Cancer Center
2017
24
11
PMIDPaper TitleJournal TitlePublished Year
35973199Targeted therapy with the mutant IDH2 inhibitor enasidenib for high-risk IDH2-mutant myelodysplastic syndrome.Blood Adv2023
37698624Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy.Blood Cancer Discov2023
37509251Building on Foundations: Venetoclax-Based Combinations in the Treatment of Acute Myeloid Leukemia.Cancers (Basel)2023
37735426Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents.Blood Cancer J2023
37102976A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid Malignancies.Blood Cancer Discov2023
36441905Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia.Blood Adv2023
36900407Molecularly Targeted Therapy in Acute Myeloid Leukemia: Current Treatment Landscape and Mechanisms of Response and Resistance.Cancers (Basel)2023
35279700Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients.Leukemia2022
35510212Advancing the standard: venetoclax combined with intensive induction and consolidation therapy for acute myeloid leukemia.Ther Adv Hematol2022
35583199Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed acute myeloid leukemia.Am J Hematol2022
35483396Venetoclax combined with induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia: a post-hoc, propensity score-matched, cohort study.Lancet Haematol2022
36054614Contemporary outcomes in IDH-mutated acute myeloid leukemia: The impact of co-occurring NPM1 mutations and venetoclax-based treatment.Am J Hematol2022
35072370Combining Isocitrate Dehydrogenase Inhibitors With Existing Regimens in Acute Myeloid Leukemia: An Evolving Treatment Landscape.Cancer J2022
34043428Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia.J Clin Oncol2021
33885753Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax.Blood Adv2021
34376374Clinical Outcomes of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia in a County Hospital System.Clin Lymphoma Myeloma Leuk2021
32251497Outcomes of older patients with NPM1-mutated AML: current treatments and the promise of venetoclax-based regimens.Blood Adv2020
32031033Venetoclax in acute myeloid leukemia - current and future directions.Leuk Lymphoma2020
32804409Clonal evolution and treatment outcomes in hematopoietic neoplasms arising in patients with germline RUNX1 mutations.Am J Hematol2020
31056994Healthcare expenditures of older patients with AML are similar between HMA and intensive induction chemotherapy.Leuk Lymphoma2019
31350639Acute Myeloid Leukemia: from Mutation Profiling to Treatment Decisions.Curr Hematol Malig Rep2019
30836091Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged â¿¥70 years.Hematol Oncol Stem Cell Ther2019
30214788Exaggerated arthropod assault: Eosinophilic dermatosis in a patient with small lymphocytic lymphoma.Clin Case Rep2018
28487504Obinutuzumab is Effective in Chronic Lymphocytic Leukemia and Rheumatoid Arthritis After Rituximab Failure: A Case Report.Am J Case Rep2017
  • 1 - 24 of 24

Recommended Authors

Maria Amaya
University of Colorado School of Medicine
Career Start Year 2018
Number of shared co-authors 0
Matthieu Duchmann
Assistance Publique-Hopitaux de Paris, Universite de Paris
Career Start Year 2015
Number of shared co-authors 0
Justin M Watts
University of Miami, Sylvester Comprehensive Cancer Center
Career Start Year 2014
Number of shared co-authors 21
Ann-Kathrin Eisfeld
The Ohio State University Comprehensive Cancer Center
Career Start Year 2011
Number of shared co-authors 4
Prapti Patel
The University of Texas Southwestern Medical Center
Career Start Year 2009
Number of shared co-authors 13
Patricia Kropf
Novant Health Cancer Institute - Elizabeth
Career Start Year 2009
Number of shared co-authors 19
Thomas K??hnke
Cancer Institute, Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 3
Friedrich St??lzel
University Hospital TU Dresden
Career Start Year 2008
Number of shared co-authors 5
Amanda Winters
University of Colorado School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Felicitas Thol
Hannover Medical School
Career Start Year 2007
Number of shared co-authors 5
Thomas Cluzeau
Universite Nice Cote d'azur, CHU de Nice
Career Start Year 2005
Number of shared co-authors 4
Raphael Itzykson
Universite Paris Cite, INSERM, CNRS
Career Start Year 2004
Number of shared co-authors 3
Jean-Baptiste Micol
INSERM U7, Universite Paris-Saclay
Career Start Year 2004
Number of shared co-authors 3
Daniel A Pollyea
University of Colorado Division of Hematology
Career Start Year 2004
Number of shared co-authors 26
Naseema Gangat
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 3
Tara L Lin
University of Kansas Medical Center
Career Start Year 2004
Number of shared co-authors 19
Christopher S Hourigan
and Blood Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 23
Christoph R??llig
Hopp Children's Cancer Center (KiTZ)
Career Start Year 2000
Number of shared co-authors 6
Lionel Ad??s
Assistance Publique des Hopitaux de Paris (AP-HP)
Career Start Year 1998
Number of shared co-authors 5
Emmanuel Raffoux
Universite Paris Diderot
Career Start Year 1998
Number of shared co-authors 4
Bruno C Medeiros
AbbVie Inc.
Career Start Year 1996
Number of shared co-authors 22
Timothy S Pardee
Comprehensive Cancer Center of Wake Forest Baptist Health, Medical Center Boulevard
Career Start Year 1995
Number of shared co-authors 1
David A Rizzieri
Duke University Medical Center
Career Start Year 1995
Number of shared co-authors 10
Michael Heuser
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 8
Jorge Cortes
Georgia Cancer Center
Career Start Year 1991
Number of shared co-authors 21
Claude Gardin
Avicenne Hospital
Career Start Year 1990
Number of shared co-authors 0
Daniel J DeAngelo
Dana-Farber Cancer Institute
Career Start Year 1989
Number of shared co-authors 17
Richard M Stone
Dana Farber Cancer Institute
Career Start Year 1986
Number of shared co-authors 18
Herv?? Dombret
Institut de Recherche Saint-Louis, Universite de Paris
Career Start Year 1984
Number of shared co-authors 4
Martin S Tallman
Memorial Sloan-Kettering Cancer Center
Career Start Year 1982
Number of shared co-authors 12

Collaborators

Courtney D DiNardo
UT MD Anderson Cancer Center
Co-authored papers 15
Gautam Borthakur
MD Anderson Cancer Center
Co-authored papers 10
Farhad Ravandi
University of Texas M.D. Anderson Cancer Center
Co-authored papers 10
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Co-authored papers 10
Guillermo Garcia-Manero
MD Anderson Cancer Center
Co-authored papers 9
Elie Traer
Oregon Health & Science University
Co-authored papers 3
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Co-authored papers 3
Gabrielle Meyers
Oregon Health and Science University
Co-authored papers 3
Rachel J Cook
Oregon Health and Science University
Co-authored papers 3
Richard T Maziarz
Oregon Health & Science University
Co-authored papers 3
Jessica Leonard
Oregon Health & Science University
Co-authored papers 2
Jennifer N Saultz
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 2
Steven M Kornblau
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Daniel Bottomly
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Brandon Hayes-Lattin
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 2
Laura F Newell
Oregon Health and Science University
Co-authored papers 2
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 2
Stephen E Spurgeon
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 2
Ronan Swords
Oregon Health and Science University
Co-authored papers 2
Brian J Druker
Oregon Health & Science University
Co-authored papers 2
Nicola Long
Oregon Health and Science University
Co-authored papers 2
Ariane Huang
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 1
Tamilla Nechiporuk
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 1
Rashmi Kanagal-Shamanna
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Sunil Kumar Joshi
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 1
Jessica Minnier
Louis Stokes Cleveland VA Medical Center Cleveland
Co-authored papers 1
Bill H Chang
Oregon Health and Science University
Co-authored papers 1
Jennifer Dunlap
Oregon Health & Science University
Co-authored papers 1
Charles A Dibb
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 1
Christopher A Eide
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Release 1.2